Literature DB >> 33229027

Proinflammatory Cytokine Dysregulation and Cognitive Dysfunction Among Patients with Remitted Bipolar I and II Disorders.

Mao-Hsiu Hua1, Mu-Hong Chen2, Ju-Wei Hsu3, Kai-Lin Huang3, Shih-Jen Tsai3, Cheng-Ta Li3, Ya-Mei Bai4.   

Abstract

BACKGROUND: Euthymic patients with bipolar disorder reportedly demonstrated increased levels of proinflammatory cytokines and cognitive function deficits. Because uncertain differences exist in cognitive function and proinflammatory cytokines between remitted bipolar I (BD1) and bipolar II (BD2) disorders, we performed this study to further investigate these differences.
METHOD: We enrolled 58 patients with remitted BD1 and 27 with remitted BD2, and matched them for age and sex with 51 controls. Proinflammatory cytokines, including soluble interleukin-6 receptor (sIL-6R), C-reactive protein, and soluble tumor necrosis factor receptor 1 (sTNFR1) were measured, and performance in the Word List Memory Task (WLMT) and Wisconsin Card Sorting Task (WCST) was assessed.
RESULTS: Significantly elevated levels of sTNFR1 were observed among patients with BD1 (p < .001) and BD2 (p = .038) compared with the controls; however, they did not differ between patients with BD1 and BD2 (p =.130). Working memory deficit measured by the WLMT was significantly greater in patients with BD1 (p < .001) and BD2 (p < .05) compared with controls, but did not differ between patients with BD1 and BD2 (p > 0.1). Furthermore, sTNFR1 levels were negatively correlated with cognitive function measured using the WLMT and WCST (all p < .05). DISCUSSION: Our results showed that euthymic patients with BD1 and BD2 showed similar levels of sTNFR1 and cognitive function (especially working memory) impairments. Further investigation is required to explore whether a common pathophysiology may contribute to the shared inflammatory and cognitive alterations between BD1 and BD2.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Bipolar I disorder; Bipolar II disorder; Cognitive function; Proinflammatory cytokines

Mesh:

Substances:

Year:  2020        PMID: 33229027     DOI: 10.1016/j.jad.2020.11.079

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  1 in total

1.  Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction.

Authors:  Mu-Hong Chen; Yu-Li Liu; Hsiang-Wei Kuo; Shih-Jen Tsai; Ju-Wei Hsu; Kai-Lin Huang; Pei-Chi Tu; Ya-Mei Bai
Journal:  Int J Neuropsychopharmacol       Date:  2022-02-11       Impact factor: 5.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.